Models of the human skin must combine the relevant biological contents and suitable biomaterials with the correct spatial organization. Performing compound screening on such in vitro models also requires fast and reproducible production methods of the models.
Elisa Lenzi +7 more
wiley +1 more source
Monoclonal antibody formulations: a quantitative analysis of marketed products and patents. [PDF]
Peng Y +6 more
europepmc +1 more source
Monoclonal antibodies specific for a murine cytotoxic T-lymphocyte clone.
Uwe D. Staerz +4 more
openalex +2 more sources
Identification of functional regions on the tail of Acanthamoeba myosin-II using recombinant fusion proteins. I. High resolution epitope mapping and characterization of monoclonal antibody binding sites. [PDF]
David L. Rimm +5 more
openalex +1 more source
Next‐Generation Psoriasis Therapy – With advanced dendrimer‐based formulations, this study paves the way for highly effective, skin‐permeable treatments. Encapsulated in fluid catanionic vesicles, IMD‐006 and its analogues show promising anti‐psoriatic effects offering a targeted, non‐invasive approach to managing chronic skin inflammation.
Ranime Jebbawi +10 more
wiley +1 more source
Case Reports of Teprotumumab as Treatment for Monoclonal Antibody-Induced Thyroid Orbitopathy. [PDF]
Moon J +4 more
europepmc +1 more source
Commercial vascular grafts are made from ePTFE, a highly hydrophobic, foreign material that fails at a high rate in small‐diameter applications. Plasma polymer nanoparticles (PPN) are a versatile material functionalisation tool, used here to present fibrillin‐1 fragment PF8 on the graft surface.
Bob S. L. Lee +9 more
wiley +1 more source
Optimising Monoclonal Antibody Drug Development for Inflammatory Bowel Disease. [PDF]
Colwill M +3 more
europepmc +1 more source
A New Marker on Chicken Hematopoietic Cells isDefined by a Monoclonal Antibody Raised Against a V ßChain of the Human TCR [PDF]
Anne-Sophie Lacoste-Eleaume +6 more
openalex +1 more source
Multivalent Protein Nanorings for Broad and Potent SARS‐CoV‐2 Neutralization
A protein‐only, modular multivalent nanoscaffold displaying 20 anchor points, decorated with two different binders (10 of each), targeting the SARS‐CoV‐2 receptor‐binding domain is presented. The construct self‐assembles into stable, biocompatible, homogeneous nanoparticles, exhibit synergistic binding with fM IC50 values. It also detects spike at 9 ng
Molood Behbahanipour +11 more
wiley +1 more source

